• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Statins Fail to Slow Progression of Small AAAs

The prescription of statin therapy does not slow the expansion of abdominal aortic aneurysms (AAA), according to the results of new study.[1] Similarly, there was no association with AAA expansion and LDL- and total-cholesterol levels, report investigators.

The negative results, according to lead author Dr. Craig Ferguson (James Cook University, Queensland, Australia), highlight the "need for ongoing preclinical studies and randomized trials designed to develop medication targeted specifically at reducing AAA growth."

Publishing the findings in the February 2010 issue of the American Heart Journal, the authors point out that most AAAs detected by screening programs measure < 55 mm in diameter, which is too small for surgery. As a result, the aneurysm is treated with further monitoring until it expands above the intervention threshold. Data from some small observational studies have suggested that statin therapy might be a noninvasive way of slowing the progression of the AAA.

In total, 652 patients with a small AAA were included in the study. Of these patients, 349 were prescribed statins, the most common being simvastatin and atorvastatin. Despite treatment, however, AAA growth rates were similar in both treatment arms. Adjusting for baseline characteristics, researchers report that statin prescription was not associated with AAA growth. LDL- and total-cholesterol levels were also not associated with AAA growth rates, despite significantly lower cholesterol levels in the treatment arm.

"Thus, our findings support other evidence suggesting that the mechanisms involved in AAA progression are distinct from those of atherosclerosis," writes Ferguson and colleagues.
Asked by heartwire if AAA patients are ever treated with statins, Dr. Steven Nissen (Cleveland Clinic, Ohio), who was not part of the current study, said they weren't because there is no evidence to support their use.

In the current study, individuals with diabetes were significantly more likely to have an above-the-median expansion of the aneurysm, a finding that has been reported in other trials.

1. Ferguson CD, Clancy P, Bourke B, et al. Association of statin prescription with small abdominal aortic aneurysm. Am Heart J 2010;159:307-311.

Source: http://www.theheart.org/article/1045383.do

image description image description


				

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications